RIOUX PATRICE
SEC Form 4 insider trading activity
RIOUX PATRICE has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.
On the most recent filing, RIOUX PATRICE is listed as Insider at Monopar Therapeutics. Inside the rolling window, RIOUX PATRICE reported no open-market purchases and 1 open-market sale totaling $111 in MNPR.
Companies traded
Other insiders at MNPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$111
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has RIOUX PATRICE made?
RIOUX PATRICE has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does RIOUX PATRICE trade?
RIOUX PATRICE has filed SEC Form 4 disclosures for 1 company, including MNPR.
When was RIOUX PATRICE's most recent SEC Form 4 filing?
RIOUX PATRICE's most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.
What is RIOUX PATRICE's total buy and sell value in the current window?
Inside the rolling retention window, RIOUX PATRICE bought $0 and sold $111 based on SEC Form 4 filings.
What was RIOUX PATRICE's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1 MNPR shares on 2026-08-26, worth $111, per SEC Form 4 filings.